Prophylactic Antibiotics for Skin Incision
For most clean and clean-contaminated surgical procedures requiring skin incision, administer cefazolin 2g IV slowly 15-60 minutes before incision as a single dose, with re-dosing of 1g if the procedure exceeds 4 hours. 1
Core Principles of Antibiotic Prophylaxis
The fundamental approach to surgical antibiotic prophylaxis is straightforward and evidence-based:
Timing is Critical
- Administer 15-60 minutes prior to skin incision - this window ensures adequate tissue levels at the time bacteria are introduced 2, 3
- The infusion must be completed before incision, ideally 30 minutes before 1
- Never delay administration until after incision - this significantly reduces efficacy
Standard Dosing by Procedure Type
Clean procedures with prosthetic material (orthopedic, cardiac, vascular):
- Cefazolin 2g IV slow as first-line agent 1
- Re-inject 1g if duration exceeds 4 hours
- Alternative: Cefamandole or cefuroxime 1.5g IV (re-inject 0.75g if duration exceeds 2 hours)
Clean-contaminated procedures (thoracic, some vascular):
- Aminopenicillin + beta-lactamase inhibitor 2g IV 1
- Or cefamandole/cefuroxime 1.5g IV
Trauma and contaminated wounds:
- Stage I open fractures: Cefazolin 2g IV 1
- Stage II-III open fractures: Aminopenicillin + beta-lactamase inhibitor 2g IV, continue up to 48 hours maximum 1
Beta-Lactam Allergy Alternatives
For patients with documented beta-lactam allergy:
- Vancomycin 30 mg/kg IV over 120 minutes 1
- The 120-minute infusion must end at the latest at the beginning of the procedure, preferably 30 minutes before
- Alternative: Clindamycin 900 mg IV slow (± gentamicin 5 mg/kg/day for contaminated procedures)
Specific Vancomycin Indications
Beyond allergy, vancomycin is indicated for:
- Suspected or proven MRSA colonization
- Reoperation in units with MRSA ecology
- Previous antibiotic therapy 1
Duration: Single Dose is Standard
Critical principle: Prophylaxis is NOT therapy 2
- Most procedures require only a single preoperative dose
- Maximum duration: 24 hours for prosthetic joint surgery 1
- Continuing antibiotics postoperatively increases toxicity, superinfections, and resistance without reducing infection rates 2
Re-dosing During Long Procedures
- Cefazolin: Re-inject 1g at 4 hours intraoperatively 1
- Cefamandole/cefuroxime: Re-inject 0.75g at 2 hours intraoperatively 1
- If blood loss exceeds 1500 mL: Consider additional dose 3-4 hours after initial dose 3
Special Populations
Morbid obesity (BMI >35 kg/m²):
- Consider doubling the antibiotic dose 3
- Standard 2g cefazolin may be insufficient due to increased volume of distribution
Cesarean section:
- Cefazolin 2g IV before skin incision significantly reduces postpartum endometritis compared to administration at cord clamping 4, 5
- Also reduces wound infections without adverse neonatal effects 5
Procedures NOT Requiring Prophylaxis
The guidelines are equally clear about when antibiotics are unnecessary:
- Arthroscopy without implant 1
- Extra-articular soft tissue surgery without implant 1
- Closed globe eye surgery 1
- Diagnostic laparoscopy without vaginal/digestive incision 1
- Simple breast lumpectomy 1
- Vein surgery (unless specific risk factors) 1
Common Pitfalls to Avoid
- Administering antibiotics too early (>60 minutes before incision) - tissue levels may be inadequate
- Continuing prophylaxis postoperatively - increases harm without benefit 2
- Using broad-spectrum agents unnecessarily - cefazolin provides adequate coverage for most procedures 6
- Inadequate dosing in obese patients - standard doses may be insufficient 3
- Forgetting to re-dose during prolonged procedures - tissue levels decline after 2-4 hours depending on agent
Target Organisms by Procedure
The choice of antibiotic targets the most common pathogens:
- Clean procedures: S. aureus, S. epidermidis 1
- Cardiac/vascular: S. aureus, S. epidermidis, some gram-negatives 1
- Orthopedic: Staphylococci, streptococci 1
- Contaminated wounds: Add anaerobic coverage with aminopenicillin + beta-lactamase inhibitor 1
This evidence-based approach reduces surgical site infection rates from 3-5% to <1% in prosthetic joint surgery 1, with similar benefits demonstrated across other surgical specialties when protocols are followed rigorously.